ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

microRNA-671-5p reduces tumorigenicity of ovarian cancer via suppressing HDAC5 and HIF-1α expression

Peng, Dongxian; Wu, Tingting; Wang, Junxia; Huang, Jie; Zheng, Lijiao; Wang, Pingping; Li, Junpeng; Wu, Lin; Luo, Min*南方医科大学
Chemico-Biological Interactions2022-3-1DOI: 10.1016/j.cbi.2021.109780
9被引4阅读
引用收藏
分享

摘要

Objective: microRNA (miR)-based therapeutic reference has been established and expanded in the treatment of cancers. For this reason, we explored how miR-671-5p regulated tumorigenicity of ovarian cancer (OC) through regulating histone deacetylase 5 (HDAC5) and hypoxia-inducible factor-1 alpha (HIF-1 alpha). Methods: miR-671-5p, HDAC5 and HIF-1 alpha expression levels were determined in OC clinical tissues. The OC cell line H8910 was screened and transfected with the vectors that altered miR-671-5p, HDAC5 and HIF-1 alpha levels. Finally, the proliferation, migration, invasion and apoptosis of the transfected H8910 cells were determined and the role of miR-671-5p and HDAC5 in vivo tumor growth was further discussed. Results: Low expression miR-671-5p and high expression HDAC5 and HIF-1 alpha levels were tested in OC tissues. Up regulating miR-671-5p or down-regulating HDAC5 or HIF-1 alpha suppressed proliferation, migration, invasion and augmented apoptosis of H8910 cells while silenced miR-671-5p or enhanced HDAC5 caused the opposite consequences. Overexpression of HDAC5 reduced while depletion of HDAC5 enhanced the influence of up-regulated miR-671-5p on OC cell growth. In animal models, suppressing miR-671-5p or promoting HDAC5 encouraged OC tumor growth. Conclusion: A summary delineates that miR-671-5p reduces tumorigenicity of OC via suppressing HDAC5 and HIF-1 alpha expression levels.

学科与关键词

关键词
Ovarian cancermicroRNA-671-5pHistone deacetylase 5Hypoxia-inducible factor-1 alphaTumorigenicityProliferation
相关
加载中…
  • microRNA-671-5p reduces tumorigenicity of ovarian cancer via suppressing HDAC5 and HIF-1α expression (vol 355, 109780, 2022)
    Peng, Dongxian; Wu, Tingting; Wang, Junxia; Huang, Jie; Zheng, Lijiao; Wang, Pingping; Li, Junpeng; Wu, Lin; Luo, Min*Chemico-Biological Interactions, 2022, 360: 109951.
  • MicroRNA-409-5p inhibits cell proliferation, and induces G2/M phase arrest and apoptosis by targeting DLGAP5 in ovarian cancer cells
    Li, Weiwei; Lin, Ji; Huang, Jianfen; Chen, Zhuoying; Sheng, Qunying; Yang, Fang; Yang, Xue; Cui, Xiaojie*Oncology Letters, 2022, 24(2): 261.被引 2
  • Downregulation of Foxo3 and TRIM31 by miR-551b in side population promotes cell proliferation, invasion, and drug resistance of ovarian cancer
    Wei, Zhentong; Liu, Yan; Wang, Yishu; Zhang, Yandong; Luo, Qinghua; Man, Xiaxia; Wei, Feng*; Yu, Xiaowei*MEDICAL ONCOLOGY, 2016, 33(11): 126.被引 38
查看全部 →

发表信息

论文状态
公开发表
期刊
Chemico-Biological Interactions
发表日期
2022-03-01
卷期
第 355 卷
页码
109780
DOI
10.1016/j.cbi.2021.109780
语言
ENGLISH
期刊等级
2区
成果收录
SCIE

作者

  • P

    Peng, Dongxian (第一作者)

    southern med univ

  • W

    Wu, Tingting

查看全部 9 位作者收起作者
  • W

    Wang, Junxia

  • H

    Huang, Jie

    southern med univ

  • Z

    Zheng, Lijiao

    southern med univ

  • W

    Wang, Pingping

    southern med univ

  • L

    Li, Junpeng

  • W

    Wu, Lin

  • L

    Luo, Min (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417